{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:03:25Z","timestamp":1790957005926,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA043982"],"award-info":[{"award-number":["R01DA043982"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5R01DA043982-02"],"award-info":[{"award-number":["5R01DA043982-02"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA043982"],"award-info":[{"award-number":["R01DA043982"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5R01DA043982-02"],"award-info":[{"award-number":["5R01DA043982-02"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cannabidiol (CBD), one of the main components of cannabis, is generally considered safe. CBD crosses the placenta and its use during pregnancy is steadily increasing, the impact of gestational CBD\u2019s effects on prenatal life and neurodevelopment are poorly understood. Here, we combined behavioral approaches and deep learning analysis to assess the sex-dependent neonatal behavior of CBD exposed progeny. Gestating C57BL6\/J dams were exposed daily with vehicle or CBD (3\u2009mg\/Kg, s.c.), from gestational day 5 to 18. Body weight, pup ultrasound vocalizations (USVs, PND 10) and homing behavior (PND 13) were quantified in the progeny. Thus, male (but not female) pups from CBD-treated dams gained more weight than sham. There were sex-dependent differences in the coarse characteristics of ultrasonic vocalizations. Prenatally-CBD exposed male pups emitted shorter calls, whereas CBD females made more high frequency calls when compared with their control counterparts. There were significant qualitative changes in the syllabic USV repertoire reflected in call typologies and communication patterns. Finally, the homing behavior test showed that CBD-exposed females presented a greater vulnerability to gestational CBD than males. Only CBD-exposed female pups showed reduced motor and discriminatory abilities. Together the results suggest a sexual divergence in the consequences of in utero CBD exposure on neonates at early developmental ages, which may be predictive of adult psychopathology. Given the extent of cannabis and CBD use worldwide, these findings challenge the idea that CBD is a universally safe compound and reveal the need for additional studies on the effect of perinatal CBD exposure.<\/jats:p>","DOI":"10.1038\/s41398-022-02271-8","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:03:08Z","timestamp":1670245388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["In utero exposure to cannabidiol disrupts select early-life behaviors in a sex-specific manner"],"prefix":"10.1038","volume":"12","author":[{"given":"Daniela","family":"Iezzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9279-1804","authenticated-orcid":false,"given":"Alba","family":"Caceres-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Chavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-6208","authenticated-orcid":false,"given":"Olivier J. J.","family":"Manzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"2271_CR1","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.1523\/JNEUROSCI.1165-19.2019","volume":"39","author":"YL Hurd","year":"2019","unstructured":"Hurd YL, Manzoni OJ, Pletnikov MV, Lee FS, Bhattacharyya S, Melis M. Cannabis and the developing brain: insights into its long-lasting effects. J Neurosci. 2019;39:8250\u20138.","journal-title":"J Neurosci"},{"key":"2271_CR2","doi-asserted-by":"publisher","first-page":"624275","DOI":"10.3389\/fpsyt.2020.624275","volume":"11","author":"MG Nashed","year":"2021","unstructured":"Nashed MG, Hardy DB, Laviolette SR. Prenatal cannabinoid exposure: emerging evidence of physiological and neuropsychiatric abnormalities. Front Psychiatry. 2021;11:624275.","journal-title":"Front Psychiatry"},{"key":"2271_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/bcpt.13710","volume":"130","author":"J Peng","year":"2022","unstructured":"Peng J, Fan M, An C, Ni F, Huang W, Luo J. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic Clin Pharm Toxicol. 2022;130:439\u201356.","journal-title":"Basic Clin Pharm Toxicol"},{"key":"2271_CR4","doi-asserted-by":"crossref","unstructured":"Iannotti FA, di Marzo V, Petrosino S. Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders. Vol. 62, Progress in Lipid Research. Elsevier Ltd; 2016. p. 107\u201328.","DOI":"10.1016\/j.plipres.2016.02.002"},{"key":"2271_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2217\/fnl.11.27","volume":"6","author":"CS Wu","year":"2011","unstructured":"Wu CS, Jew CP, Lu HC. Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future Neurol. 2011;6:459\u201380.","journal-title":"Future Neurol"},{"key":"2271_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.tins.2019.08.010","volume":"42","author":"AF Scheyer","year":"2019","unstructured":"Scheyer AF, Melis M, Trezza V, Manzoni OJJ. Consequences of perinatal cannabis exposure. Trends Neurosci. 2019;42:871\u201384.","journal-title":"Trends Neurosci"},{"key":"2271_CR7","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/bdr2.1766","volume":"112","author":"KS Grant","year":"2020","unstructured":"Grant KS, Conover E, Chambers CD. Update on the developmental consequences of cannabis use during pregnancy and lactation. Birth Defects Res. 2020;112:1126\u201338.","journal-title":"Birth Defects Res"},{"key":"2271_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41583-021-00465-5","volume":"22","author":"A Bara","year":"2021","unstructured":"Bara A, Ferland JMN, Rompala G, Szutorisz H, Hurd YL. Cannabis and synaptic reprogramming of the developing brain. Nat Rev Neurosci. 2021;22:423\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"2271_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pharmthera.2018.10.006","volume":"195","author":"MAP Bloomfield","year":"2019","unstructured":"Bloomfield MAP, Hindocha C, Green SF, Wall MB, Lees R, Petrilli K, et al. The neuropsychopharmacology of cannabis: A review of human imaging studies. Pharm Ther. 2019;195:132\u201361.","journal-title":"Pharm Ther"},{"key":"2271_CR10","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1111\/bcp.13618","volume":"84","author":"CPL Grof","year":"2018","unstructured":"Grof CPL. Cannabis, from plant to pill. Br J Clin Pharm. 2018;84:2463\u20137.","journal-title":"Br J Clin Pharm"},{"key":"2271_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488611798280924","volume":"6","author":"M Machado Bergamaschi","year":"2011","unstructured":"Machado Bergamaschi M, Helena Costa Queiroz R, Waldo Zuardi A, Alexandre S, Crippa J. Safety and side effects of cannabidiol, a cannabis sativa constituent. Curr Drug Saf. 2011;6:237\u201349.","journal-title":"Curr Drug Saf"},{"key":"2271_CR12","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.3390\/molecules24142583","volume":"24","author":"C Calpe-L\u00f3pez","year":"2019","unstructured":"Calpe-L\u00f3pez C, Garc\u00eda-Pardo MP, Aguilar MA. Cannabidiol treatment might promote resilience to cocaine and methamphetamine use disorders: a review of possible mechanisms. Molecules. 2019;24:2583.","journal-title":"Molecules"},{"key":"2271_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/FBP.0000000000000544","volume":"31","author":"Y Razavi","year":"2020","unstructured":"Razavi Y, Shabani R, Mehdizadeh M, Haghparast A. Neuroprotective effect of chronic administration of cannabidiol during the abstinence period on methamphetamine-induced impairment of recognition memory in the rats. Behavioural Pharmacol. 2020;31:385\u201396.","journal-title":"Behavioural Pharmacol"},{"key":"2271_CR14","doi-asserted-by":"publisher","first-page":"108948","DOI":"10.1016\/j.neuropharm.2022.108948","volume":"207","author":"S Karimi-Haghighi","year":"2022","unstructured":"Karimi-Haghighi S, Razavi Y, Iezzi D, Scheyer AF, Manzoni O, Haghparast A. Cannabidiol and substance use disorder: Dream or reality. Neuropharmacology. 2022;207:108948.","journal-title":"Neuropharmacology"},{"key":"2271_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejim.2018.01.001","volume":"49","author":"R Abuhasira","year":"2018","unstructured":"Abuhasira R, Shbiro L, Landschaft Y. Medical use of cannabis and cannabinoids containing products\u2014Regulations in Europe and North America. Eur J Intern Med. 2018;49:2\u20136.","journal-title":"Eur J Intern Med"},{"key":"2271_CR16","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1007\/s00204-021-03122-z","volume":"95","author":"P Alves","year":"2021","unstructured":"Alves P, Amaral C, Teixeira N, Correia-da-Silva G. Cannabidiol disrupts apoptosis, autophagy and invasion processes of placental trophoblasts. Arch Toxicol. 2021;95:3393\u2013406.","journal-title":"Arch Toxicol"},{"key":"2271_CR17","doi-asserted-by":"crossref","unstructured":"Sarrafpour S, Urits I, Powell J, Nguyen D, Callan J, Orhurhu V, et al. Considerations and implications of cannabidiol use during pregnancy. Curr Pain Headache Rep. 2020;24:38.","DOI":"10.1007\/s11916-020-00872-w"},{"key":"2271_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1124\/dmd.120.000270","volume":"49","author":"W Ochiai","year":"2021","unstructured":"Ochiai W, Kitaoka S, Kawamura T, Hatogai J, Harada S, Iizuka M, et al. Maternal and fetal pharmacokinetic analysis of cannabidiol during pregnancy in mice. Drug Metab Disposition. 2021;49:337\u201343.","journal-title":"Drug Metab Disposition"},{"key":"2271_CR19","doi-asserted-by":"crossref","unstructured":"Maciel I de S, de Abreu GHD, Johnson CT, Bonday R, Bradshaw HB, et al. Perinatal CBD or THC exposure results in lasting resistance to fluoxetine in the forced swim test: reversal by fatty acid amide hydrolase inhibition. Cannabis Cannabinoid Res. 2021;X:1\u201310.","DOI":"10.1089\/can.2021.0015"},{"key":"2271_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-020-00993-4","volume":"13","author":"NM Wanner","year":"2021","unstructured":"Wanner NM, Colwell M, Drown C, Faulk C. Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice. Clin Epigenetics. 2021;13:1\u201316.","journal-title":"Clin Epigenetics"},{"key":"2271_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1523\/ENEURO.0144-20.2020","volume":"7","author":"AF Scheyer","year":"2020","unstructured":"Scheyer AF, Borsoi M, Pelissier-Alicot AL, Manzoni OJJ. Maternal exposure to the cannabinoid agonist WIN 55,12,2 during lactation induces lasting behavioral and synaptic alterations in the rat adult offspring of both sexes. eNeuro. 2020;7:1\u201311.","journal-title":"eNeuro"},{"key":"2271_CR22","doi-asserted-by":"crossref","unstructured":"Coffey KR, Marx RG, Neumaier JF. DeepSqueak: a deep learning-based system for detection and analysis of ultrasonic vocalizations. Neuropsychopharmacology. 2019;44:859\u201368.","DOI":"10.1038\/s41386-018-0303-6"},{"key":"2271_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/tp.2016.182","volume":"6","author":"M Servadio","year":"2016","unstructured":"Servadio M, Melancia F, Manduca A, di Masi A, Schiavi S, Cartocci V, et al. Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid. Transl Psychiatry. 2016;6:1\u201311.","journal-title":"Transl Psychiatry"},{"key":"2271_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jamapsychiatry.2020.2902","volume":"78","author":"SE Paul","year":"2021","unstructured":"Paul SE, Hatoum AS, Fine JD, Johnson EC, Hansen I, Karcher NR, et al. Associations between prenatal cannabis exposure and childhood outcomes: results from the ABCD study. JAMA Psychiatry. 2021;78:64\u201376.","journal-title":"JAMA Psychiatry"},{"key":"2271_CR25","doi-asserted-by":"crossref","unstructured":"Simola N, Granon S. Ultrasonic vocalizations as a tool in studying emotional states in rodent models of social behavior and brain disease. Neuropharmacology. 2019;159:107420.","DOI":"10.1016\/j.neuropharm.2018.11.008"},{"key":"2271_CR26","doi-asserted-by":"crossref","unstructured":"Brudzynski SM. Biological functions of rat ultrasonic vocalizations, arousal mechanisms, and call initiation. Brain Sci. 2021;11:605.","DOI":"10.3390\/brainsci11050605"},{"key":"2271_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.36234","volume":"7","author":"A Bara","year":"2018","unstructured":"Bara A, Manduca A, Bernabeu A, Borsoi M, Serviado M, Lassalle O, et al. Sex-dependent effects of in utero cannabinoid exposure on cortical function. Elife. 2018;7:1\u201331.","journal-title":"Elife"},{"key":"2271_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tips.2006.12.004","volume":"28","author":"T Harkany","year":"2007","unstructured":"Harkany T, Guzm\u00e1n M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharm Sci. 2007;28:83\u201392.","journal-title":"Trends Pharm Sci"},{"key":"2271_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00213-008-1162-3","volume":"198","author":"V Trezza","year":"2008","unstructured":"Trezza V, Campolongo P, Cassano T, Macheda T, Dipasquale P, Carrat\u00f9 MR, et al. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacol (Berl). 2008;198:529\u201337.","journal-title":"Psychopharmacol (Berl)"},{"key":"2271_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/bph.14879","volume":"177","author":"A Manduca","year":"2020","unstructured":"Manduca A, Servadio M, Melancia F, Schiavi S, Manzoni OJ, Trezza V. Sex-specific behavioural deficits induced at early life by prenatal exposure to the cannabinoid receptor agonist WIN55, 212-2 depend on mGlu5 receptor signalling. Br J Pharm. 2020;177:449\u201363.","journal-title":"Br J Pharm"},{"key":"2271_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1471-0528.2002.01020.x","volume":"109","author":"DM Fergusson","year":"2002","unstructured":"Fergusson DM, Horwood LJ, Northstone K. Maternal use of cannabis and pregnancy outcome. BJOG. 2002;109:21\u20137.","journal-title":"BJOG"},{"key":"2271_CR32","doi-asserted-by":"crossref","unstructured":"Gunn JKL, Rosales CB, Center KE, Nu\u00f1ez A, Gibson SJ, Christ C, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6:e009986.","DOI":"10.1136\/bmjopen-2015-009986"},{"key":"2271_CR33","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.biopsych.2019.08.023","volume":"87","author":"AF Scheyer","year":"2020","unstructured":"Scheyer AF, Borsoi M, Wager-Miller J, Pelissier-Alicot AL, Murphy MN, Mackie K, et al. Cannabinoid exposure via lactation in rats disrupts perinatal programming of the Gamma-Aminobutyric acid trajectory and select early-life behaviors. Biol Psychiatry. 2020;87:666\u201377.","journal-title":"Biol Psychiatry"},{"key":"2271_CR34","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0306-4522(97)00348-5","volume":"82","author":"NE Buckley","year":"1997","unstructured":"Buckley NE, Hansson S, Harta G, Mezey \u00c9. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience. 1997;82:1131\u201349.","journal-title":"Neuroscience"},{"key":"2271_CR35","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-L\u00f3pez MT, Arco R, Decara J, V\u00e1zquez M, Blanco RN, Al\u00e9n F, et al. Exposure to a highly caloric palatable diet during the perinatal period affects the expression of the endogenous cannabinoid system in the brain, liver and adipose tissue of adult rat offspring. PLoS One. 2016;11:e0173653.","DOI":"10.1371\/journal.pone.0165432"},{"key":"2271_CR36","first-page":"154","volume":"19","author":"ZM Coskun","year":"2016","unstructured":"Coskun ZM, Bolkent S. Evaluation of \u03949-tetrahydrocannabinol metabolites and oxidative stress in type 2 diabetic rats. Iran J Basic Med Sci. 2016;19:154.","journal-title":"Iran J Basic Med Sci"},{"key":"2271_CR37","doi-asserted-by":"crossref","unstructured":"Shrestha N, Cuffe JSM, Hutchinson DS, Headrick JP, Perkins AV, McAinch AJ, et al. Peripheral modulation of the endocannabinoid system in metabolic disease. Drug Disco Today. 2018;23:592\u2013604.","DOI":"10.1016\/j.drudis.2018.01.029"},{"key":"2271_CR38","doi-asserted-by":"crossref","unstructured":"Moore BF, Sauder KA, Shapiro ALB, Crume T, Kinney GL, Dabelea D. Fetal exposure to cannabis and childhood metabolic outcomes: the healthy start study. J Clin Endocrinol Metab. 2022;107:e2862\u201369.","DOI":"10.1210\/clinem\/dgac101"},{"key":"2271_CR39","doi-asserted-by":"crossref","unstructured":"Oke SL, Lee K, Papp R, Laviolette SR, Hardy DB. In utero exposure to \u03b49-tetrahydrocannabinol leads to postnatal catch-up growth and dysmetabolism in the adult rat liver. Int J Mol Sci. 2021;22:7502.","DOI":"10.3390\/ijms22147502"},{"key":"2271_CR40","doi-asserted-by":"crossref","unstructured":"Zhu Z, Cao F, Li X. Epigenetic programming and fetal metabolic programming. Front Endocrinol (Lausanne). 2019;10:764.","DOI":"10.3389\/fendo.2019.00764"},{"key":"2271_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0166-4328(01)00277-7","volume":"125","author":"I Branchi","year":"2001","unstructured":"Branchi I, Santucci D, Alleva E. Ultrasonic vocalisation emitted by infant rodents: a tool for assessment of neurobehavioural development. Behavioural Brain Res. 2001;125:49\u201356.","journal-title":"Behavioural Brain Res"},{"key":"2271_CR42","doi-asserted-by":"publisher","first-page":"13.12.1","DOI":"10.1002\/0471140856.tx1312s30","volume":"30","author":"I Branchi","year":"2006","unstructured":"Branchi I, Santucci D, Alleva E. Analysis of ultrasonic vocalizations emitted by infant rodents. Curr Protoc Toxicol. 2006;30:13.12.1\u201313.12.14.","journal-title":"Curr Protoc Toxicol"},{"key":"2271_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00441-013-1607-9","volume":"354","author":"M W\u00f6hr","year":"2013","unstructured":"W\u00f6hr M, Schwarting RKW. Affective communication in rodents: ultrasonic vocalizations as a tool for research on emotion and motivation. Cell Tissue Res. 2013;354:81\u201397.","journal-title":"Cell Tissue Res"},{"key":"2271_CR44","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/cercor\/bhi076","volume":"15","author":"T Antonelli","year":"2005","unstructured":"Antonelli T, Tomasini MC, Tattoli M, Cassano T, Tanganelli S, Finetti S, et al. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex. 2005;15:2013\u201320.","journal-title":"Cereb Cortex"},{"key":"2271_CR45","doi-asserted-by":"crossref","unstructured":"Hepbasli D, Gredy S, Ullrich M, Reigl A, Abe\u00dfer M, Raabe T, et al. Genotype- and age-dependent differences in ultrasound vocalizations of SPRED2 mutant mice revealed by machine deep learning. Brain Sci. 2021;11:1365.","DOI":"10.3390\/brainsci11101365"},{"key":"2271_CR46","doi-asserted-by":"crossref","unstructured":"Scattoni ML, Gandhy SU, Ricceri L, Crawley JN. Unusual repertoire of vocalizations in the BTBR T+tf\/J mouse model of autism. PLoS One. 2008;3:e3067.","DOI":"10.1371\/journal.pone.0003067"},{"key":"2271_CR47","doi-asserted-by":"crossref","unstructured":"Roy S, Watkins N, Heck D Comprehensive analysis of ultrasonic vocalizations in a mouse model of fragile X syndrome reveals limited, call type specific deficits. PLoS One. 2012;7:e44816.","DOI":"10.1371\/journal.pone.0044816"},{"key":"2271_CR48","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/aur.1564","volume":"9","author":"A\u00d6 Sungur","year":"2016","unstructured":"Sungur A\u00d6, Schwarting RKW, W\u00f6hr M. Early communication deficits in the Shank1 knockout mouse model for autism spectrum disorder: Developmental aspects and effects of social context. Autism Res. 2016;9:696\u2013709.","journal-title":"Autism Res"},{"key":"2271_CR49","doi-asserted-by":"crossref","unstructured":"W\u00f6hr M, Roullet FI, Hung AY, Sheng M, Crawley JN. Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One. 2011;6:e20631.","DOI":"10.1371\/journal.pone.0020631"},{"key":"2271_CR50","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.1016\/S0165-5876(99)00180-9","volume":"49","author":"K Michelsson","year":"1999","unstructured":"Michelsson K, Michelsson O. Phonation in the newborn, infant cry. Int J Pediatr Otorhinolaryngol. 1999;49:S297\u2013301.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2271_CR51","doi-asserted-by":"crossref","unstructured":"Cirulli F, Berry A, Alleva E. Early disruption of the mother-infant relationship: Effects on brain plasticity and implications for psychopathology. Neurosci Biobehav Rev. 2003;27:73\u201382.","DOI":"10.1016\/S0149-7634(03)00010-1"},{"key":"2271_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/10253890.2017.1389883","volume":"21","author":"R Orso","year":"2018","unstructured":"Orso R, Wearick-Silva LE, Creutzberg KC, Centeno-Silva A, Glusman Roithmann L, Pazzin R, et al. Maternal behavior of the mouse dam toward pups: implications for maternal separation model of early life stress. Stress. 2018;21:19\u201327.","journal-title":"Stress"},{"key":"2271_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugalcdep.2012.06.005","volume":"127","author":"SH Shin","year":"2013","unstructured":"Shin SH, Miller DP, Teicher MH. Exposure to childhood neglect and physical abuse and developmental trajectories of heavy episodic drinking from early adolescence into young adulthood. Drug Alcohol Depend. 2013;127:31\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"2271_CR54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.amepre.2017.07.007","volume":"53","author":"RM Sacks","year":"2017","unstructured":"Sacks RM, Takemoto E, Andrea S, Dieckmann NF, Bauer KW, Boone-Heinonen J. Childhood maltreatment and BMI trajectory: the mediating role of depression. Am J Prev Med. 2017;53:625\u201333.","journal-title":"Am J Prev Med"},{"key":"2271_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.yfrne.2014.11.007","volume":"36","author":"RS Bridges","year":"2015","unstructured":"Bridges RS. Neuroendocrine regulation of maternal behavior. Front Neuroendocrinol. 2015;36:178\u201396.","journal-title":"Front Neuroendocrinol"},{"key":"2271_CR56","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/3-540-26573-2_16","volume":"168","author":"J Fern\u00e1ndez-Ruiz","year":"2005","unstructured":"Fern\u00e1ndez-Ruiz J, Gonz\u00e1lez S. Cannabinoid control of motor function at the basal ganglia. Handb Exp Pharm. 2005;168:479\u2013507.","journal-title":"Handb Exp Pharm"},{"key":"2271_CR57","doi-asserted-by":"crossref","unstructured":"De Almeida DL, Devi LA. Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect. 2020;8:e00682.","DOI":"10.1002\/prp2.682"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02271-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:03:24Z","timestamp":1670245404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02271-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2271"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02271-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1811741\/v1","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"501"}}